Table 3 Viral entry pathways of animal viruses and TMD lengths (predicted from hydrophobicity plots) of proteins known to play a key role in viral entry.
S. No. | Enveloped Virus (Protein) | Known* Entry Mode | Reference(s) for* | Predicted TMD Length(s) | Mean ± Std |
---|---|---|---|---|---|
1 | HIV (gp41) | PM | 30 | 28.25 ± 2.36 | |
2 | Herpes Simplex (Env glycoprotein gH) | 28 | |||
3 | Measles (Hemagglutinin) | 30 | |||
4 | Sendai (Fusion Protein) | 25 | |||
5 | Hepatitis C (E2 glycoprotein) | CME | 17 | 10.80 ± 5.12 | |
6 | Sindbis (E1 glycoprotein) | 5 | |||
7 | Vesicular Stomatitis (Glycoprotein G) | 7 | |||
8 | Semliki Forest (E1 glycoprotein) | 15 | |||
9 | Equine Infectious Anemia (Outer membrane protein) | 10 | |||
10 | Vaccinia (A21 protein) | MPE | 8 | 20.67 ± 7.06 | |
11 | Filamentous Influenza (Hemagglutinin) | 27 | |||
12 | Cytomegalovirus (Env Glycoprotein H) | 20 | |||
13 | Respiratory Syncytial virus A (F1 protein) | 27 | |||
14 | African Swine Fever (177L) | 19 | |||
15 | Ebola (Envelope Glycoprotein) | 23 | |||
16 | SV 40 (Agnoprotein) | CAME | 10 | 13.75 ± 7.50 | |
17 | Polyoma (Agnoprotein) | 10 | |||
18 | New Castle Disease (F1 protein) | 25 | |||
19 | Echovirus 1 (Capsid protein) | 10 |